In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2

Coronavirus disease 2019, caused by the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing global pandemic that poses an unprecedented threat to the global economy and human health. Several potent inhibitors targeting SARS-CoV-2 have been published; however, most...

Full description

Bibliographic Details
Main Authors: Nalae Kang, Seong-Yeong Heo, Seon-Heui Cha, Ginnae Ahn, Soo-Jin Heo
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/20/6/399
_version_ 1797485042308481024
author Nalae Kang
Seong-Yeong Heo
Seon-Heui Cha
Ginnae Ahn
Soo-Jin Heo
author_facet Nalae Kang
Seong-Yeong Heo
Seon-Heui Cha
Ginnae Ahn
Soo-Jin Heo
author_sort Nalae Kang
collection DOAJ
description Coronavirus disease 2019, caused by the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing global pandemic that poses an unprecedented threat to the global economy and human health. Several potent inhibitors targeting SARS-CoV-2 have been published; however, most of them have failed in clinical trials. This study aimed to assess the therapeutic compounds among aldehyde derivatives from seaweeds as potential SARS-CoV-2 inhibitors using a computer simulation protocol. The absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) properties of the compounds were analyzed using a machine learning algorithm, and the docking simulation of these compounds to the 3C-like protease (Protein Data Bank (PDB) ID: 6LU7) was analyzed using a molecular docking protocol based on the CHARMm algorithm. These compounds exhibited good drug-like properties following the Lipinski and Veber rules. Among the marine aldehyde derivatives, 4-hydroxybenzaldehyde, 3-hydroxybenzaldehyde, 3,4-dihydroxybenzaldehyde, and 5-bromoprotocatechualdehyde were predicted to have good absorption and solubility levels and non-hepatotoxicity in the ADME/Tox prediction. 3-hydroxybenzaldehyde and 3,4-dihydroxybenzaldehyde were predicted to be non-toxic in TOPKAT prediction. In addition, 3,4-dihydroxybenzaldehyde was predicted to exhibit interactions with the 3C-like protease, with binding energies of −71.9725 kcal/mol. The computational analyses indicated that 3,4-dihydroxybenzaldehyde could be regarded as potential a SARS-CoV-2 inhibitor.
first_indexed 2024-03-09T23:13:09Z
format Article
id doaj.art-de2dc786f74b41c7b0212d70aaf534b3
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-09T23:13:09Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-de2dc786f74b41c7b0212d70aaf534b32023-11-23T17:41:31ZengMDPI AGMarine Drugs1660-33972022-06-0120639910.3390/md20060399In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2Nalae Kang0Seong-Yeong Heo1Seon-Heui Cha2Ginnae Ahn3Soo-Jin Heo4Jeju Marine Research Center, Korea Institute of Ocean Science and Technology (KIOST), Jeju 63349, KoreaJeju Marine Research Center, Korea Institute of Ocean Science and Technology (KIOST), Jeju 63349, KoreaDepartment of Marine Bio and Medical Sciences, Hanseo University, Seosan 31962, KoreaDepartment of Food Technology and Nutrition, Chonnam National University, Yeosu 59626, KoreaJeju Marine Research Center, Korea Institute of Ocean Science and Technology (KIOST), Jeju 63349, KoreaCoronavirus disease 2019, caused by the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing global pandemic that poses an unprecedented threat to the global economy and human health. Several potent inhibitors targeting SARS-CoV-2 have been published; however, most of them have failed in clinical trials. This study aimed to assess the therapeutic compounds among aldehyde derivatives from seaweeds as potential SARS-CoV-2 inhibitors using a computer simulation protocol. The absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) properties of the compounds were analyzed using a machine learning algorithm, and the docking simulation of these compounds to the 3C-like protease (Protein Data Bank (PDB) ID: 6LU7) was analyzed using a molecular docking protocol based on the CHARMm algorithm. These compounds exhibited good drug-like properties following the Lipinski and Veber rules. Among the marine aldehyde derivatives, 4-hydroxybenzaldehyde, 3-hydroxybenzaldehyde, 3,4-dihydroxybenzaldehyde, and 5-bromoprotocatechualdehyde were predicted to have good absorption and solubility levels and non-hepatotoxicity in the ADME/Tox prediction. 3-hydroxybenzaldehyde and 3,4-dihydroxybenzaldehyde were predicted to be non-toxic in TOPKAT prediction. In addition, 3,4-dihydroxybenzaldehyde was predicted to exhibit interactions with the 3C-like protease, with binding energies of −71.9725 kcal/mol. The computational analyses indicated that 3,4-dihydroxybenzaldehyde could be regarded as potential a SARS-CoV-2 inhibitor.https://www.mdpi.com/1660-3397/20/6/399SARS-CoV-2Coronavirus disease 2019seaweedaldehyde derivativesin silicovirtual screening
spellingShingle Nalae Kang
Seong-Yeong Heo
Seon-Heui Cha
Ginnae Ahn
Soo-Jin Heo
In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2
Marine Drugs
SARS-CoV-2
Coronavirus disease 2019
seaweed
aldehyde derivatives
in silico
virtual screening
title In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2
title_full In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2
title_fullStr In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2
title_full_unstemmed In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2
title_short In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2
title_sort in silico virtual screening of marine aldehyde derivatives from seaweeds against sars cov 2
topic SARS-CoV-2
Coronavirus disease 2019
seaweed
aldehyde derivatives
in silico
virtual screening
url https://www.mdpi.com/1660-3397/20/6/399
work_keys_str_mv AT nalaekang insilicovirtualscreeningofmarinealdehydederivativesfromseaweedsagainstsarscov2
AT seongyeongheo insilicovirtualscreeningofmarinealdehydederivativesfromseaweedsagainstsarscov2
AT seonheuicha insilicovirtualscreeningofmarinealdehydederivativesfromseaweedsagainstsarscov2
AT ginnaeahn insilicovirtualscreeningofmarinealdehydederivativesfromseaweedsagainstsarscov2
AT soojinheo insilicovirtualscreeningofmarinealdehydederivativesfromseaweedsagainstsarscov2